F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
MoMath Brings Prime Numbers to a Prime New Location
After outgrowing its original home, the National Museum of Mathematics has added new exhib…
